Dermata Therapeutics Inc. (DRMA)
Market Open
12 Jun, 13:30
NASDAQ (CM) NASDAQ (CM) Primary $
1. 22
0
0%
$
851.95K Market Cap
- P/E Ratio
- Div Yield
41,128 Volume
-1.38 Eps
$ 1.22
Previous Close Investors:
Want to track DRMA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Dermata Therapeutics Inc. (DRMA) Statistics
Valuation metrics
Market Cap 851.95K
Enterprise value -6.14M
Trailing P/E (ttm) -0.64
Forward P/E -
PEG ratio -0
Price/Sales (ttm) -
Price/Book (mrq) 0.71
Enterprise Value/Revenue -
Enterprise Value/EBITDA 0.83
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 64.95K
Average volume (90 days) 757.82K
Price summary
52-Week low 1.1
52-Week high 8
Beta -
50-Day moving average 1.27
200-Day moving average 1.74
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 1 Aug 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.95%
Return on equity -1.28%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.84
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.8
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 7.09%
Book value per share (mrq) 1.66
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
